Molecular Vision

《分子视觉》（Molecular Vision，常用缩写 Mol. Vis.）是美国埃默里大学自办的眼科分子生物学开放获取期刊，1995 年创刊，是美国国家医学图书馆收录的首个在线同行评议期刊，发表视觉系统（眼与皮层）的分子生物学、细胞生物学与遗传学研究，连续出版，2025 年影响因子 1.8。Molecular Vision (commonly abbreviated Mol. Vis.) is an open access journal on the molecular biology of vision self-published by Emory University in the United States, founded in 1995 as the first online peer-reviewed journal indexed by the National Library of Medicine, covering molecular biology, cell biology and genetics of the visual system, ocular and cortical, in continuous publication, with a 2025 impact factor of 1.8.

Scope

刊物官方宗旨为传播视觉系统研究成果，官方声明的征稿范围包括：The journal's stated aim is to disseminate research results on the visual system, with its official scope covering:

• 视觉系统分子生物学： 眼部与皮层视觉系统的分子生物学、细胞生物学与遗传学研究，涵盖视网膜、晶状体、角膜与视神经等组织。Molecular biology of the visual system: studies on the molecular biology, cell biology and genetics of the ocular and cortical visual system, covering tissues such as the retina, lens, cornea and optic nerve.
• 同行评议与快速发表： 所有投稿均经过严格同行评议，刊物不发表预印本，为作者提供快速发布重要研究结果的渠道。Peer review and rapid publication: all submissions undergo rigorous peer review, the journal does not publish preprints, and it provides authors with a rapid means of communicating important results.
• 栏目设置： 接受原创研究论文、综述与短篇通讯，亦发表眼科分子生物学领域的方法学文章。Article types: original research papers, reviews and short communications, together with methodological articles in molecular ophthalmology.

History

• 创刊与开放获取先驱： 1995 年 10 月 11 日第 1 卷第 1 期上线，由埃默里大学眼科学系的杰弗里·博特雷（Jeffrey Boatright）与约翰·尼克森（John Nickerson）创办，是开放获取概念出现前即已实行完全开放获取的期刊。Founding and open access pioneer: volume 1, article 1 went live on 11 October 1995, founded by Jeffrey Boatright and John Nickerson of the Department of Ophthalmology at Emory University, and was open access before the term itself came into widespread use.
• 出版模式： 由埃默里大学自办自出版，无商业出版商介入，自创刊起即为完全开放获取，读者可免费、无限制地访问全部内容。Publishing model: self-published by Emory University without a commercial publisher, and fully open access from its founding, with all content freely and unrestrictedly available to readers.
• 出版频率： 采用连续在线出版，每年一卷，文章按接收顺序上线并编号，因此无传统的定期刊期。Publication frequency: it operates under continuous online publication with one volume per year, where articles go live and are numbered in order of acceptance, so there are no traditional periodic issues.
• 指标走势： 影响因子在 2017 至 2021 年间为 2.2 至 2.7，2022 年为 2.2，2023 年为 1.8，2024 年为 1.4，2025 年回升至 1.8，2025 年 JCR 生化与分子生物学分区为三区。Metric trend: the impact factor ranged from 2.2 to 2.7 between 2017 and 2021, stood at 2.2 in 2022, 1.8 in 2023, 1.4 in 2024 and recovered to 1.8 in 2025, placing it in the third quartile of biochemistry and molecular biology in the 2025 JCR.

Editors

编辑部由主编、联合主编与编委会组成，成员来自眼科与视觉科学领域：The editorial office comprises the editor-in-chief, a co-editor-in-chief and an editorial board, drawn from ophthalmology and vision science:

• 主编： 约翰·尼克森（John Nickerson），埃默里大学眼科学系教授，研究方向为视网膜色素上皮细胞的基因表达调控。Editor-in-chief: John Nickerson, professor in the Department of Ophthalmology at Emory University, whose research focuses on the regulation of gene expression in retinal pigment epithelial cells.
• 联合主编： 刘奕志（Yizhi Liu），中山大学中山眼科中心主任，同时担任《分子视觉》联合主编。Co-editor-in-chief: Yizhi Liu, director of the Zhongshan Ophthalmic Center at Sun Yat-sen University, who also serves as co-editor-in-chief of Molecular Vision.
• 开放获取： 刊物为完全开放获取，全部内容免费在线发布，不向作者收取文章处理费。Open access: the journal is fully open access, with all content published online free of charge and no article processing charge levied on authors.
• 收录与分区： 收录于科学引文索引扩展版（SCIE）、Medline、PubMed、Scopus 与开放获取期刊目录（DOAJ），2026 年中科院分区为医学四区、生化与分子生物学四区、眼科学四区。Indexing and ranking: indexed in the Science Citation Index Expanded (SCIE), Medline, PubMed, Scopus and the Directory of Open Access Journals (DOAJ), and classified in the fourth quartile of medicine, biochemistry and molecular biology, and ophthalmology under the 2026 Chinese Academy of Sciences scheme.